Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

MicroRNAs in heart failure: is the picture becoming less miRky?

Melman YF, Shah R, Das S.

Circ Heart Fail. 2014 Jan;7(1):203-14. doi: 10.1161/CIRCHEARTFAILURE.113.000266. Review. No abstract available.

2.

microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.

Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z, Wang Z.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):565-74. eCollection 2014 Jan 15.

3.

MicroRNAs and the failing heart.

Mann DL.

N Engl J Med. 2007 Jun 21;356(25):2644-5. No abstract available.

PMID:
17582077
4.

Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure.

Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF, Blelloch R.

Circ Res. 2009 Sep 11;105(6):585-94. doi: 10.1161/CIRCRESAHA.109.200451. Epub 2009 Aug 13.

5.

MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes.

Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M, Kuwabara Y, Takanabe R, Hasegawa K, Kita T, Kimura T.

Biochem Biophys Res Commun. 2009 Nov 13;389(2):315-20. doi: 10.1016/j.bbrc.2009.08.136. Epub 2009 Aug 29.

PMID:
19720047
6.

Non-coding RNAs in cardiac remodeling and heart failure.

Kumarswamy R, Thum T.

Circ Res. 2013 Aug 30;113(6):676-89. doi: 10.1161/CIRCRESAHA.113.300226. Review.

7.

Small and long non-coding RNAs in cardiac homeostasis and regeneration.

Ounzain S, Crippa S, Pedrazzini T.

Biochim Biophys Acta. 2013 Apr;1833(4):923-33. doi: 10.1016/j.bbamcr.2012.08.010. Epub 2012 Aug 23. Review.

8.

Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.

Li XM, Ma YT, Yang YN, Liu F, Chen BD, Han W, Zhang JF, Gao XM.

Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1054-61. doi: 10.1111/j.1440-1681.2009.05243.x. Epub 2009 Jun 29.

PMID:
19566828
9.

Searching for miR-acles in cardiac fibrosis.

van Rooij E, Olson EN.

Circ Res. 2009 Jan 30;104(2):138-40. doi: 10.1161/CIRCRESAHA.108.192492. No abstract available.

10.

Role of microRNAs in cardiac hypertrophy and heart failure.

Wang N, Zhou Z, Liao X, Zhang T.

IUBMB Life. 2009 Jun;61(6):566-71. doi: 10.1002/iub.204. Review.

11.

Distinct functions of junD in cardiac hypertrophy and heart failure.

Ricci R, Eriksson U, Oudit GY, Eferl R, Akhmedov A, Sumara I, Sumara G, Kassiri Z, David JP, Bakiri L, Sasse B, Idarraga MH, Rath M, Kurz D, Theussl HC, Perriard JC, Backx P, Penninger JM, Wagner EF.

Genes Dev. 2005 Jan 15;19(2):208-13.

12.

MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.

van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B.

Aging Cell. 2011 Oct;10(5):769-79. doi: 10.1111/j.1474-9726.2011.00714.x. Epub 2011 May 25.

13.

Outline of proteins and signaling pathways involved in heart failure.

Bi Q.

Curr Protein Pept Sci. 2012 Nov;13(7):682-6. Review.

PMID:
23228350
14.

Functional role of miRNA in cardiac resynchronization therapy.

Sardu C, Marfella R, Santulli G, Paolisso G.

Pharmacogenomics. 2014 Jun;15(8):1159-68. doi: 10.2217/pgs.14.76. Review.

PMID:
25084208
15.

G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure.

Takefuji M, Wirth A, Lukasova M, Takefuji S, Boettger T, Braun T, Althoff T, Offermanns S, Wettschureck N.

Circulation. 2012 Oct 16;126(16):1972-82. doi: 10.1161/CIRCULATIONAHA.112.109256. Epub 2012 Sep 12.

16.

Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice.

Beetz N, Hein L, Meszaros J, Gilsbach R, Barreto F, Meissner M, Hoppe UC, Schwartz A, Herzig S, Matthes J.

Cardiovasc Res. 2009 Dec 1;84(3):396-406. doi: 10.1093/cvr/cvp251. Epub 2009 Jul 20.

17.

The emerging role of microRNAs in cardiac remodeling and heart failure.

Divakaran V, Mann DL.

Circ Res. 2008 Nov 7;103(10):1072-83. doi: 10.1161/CIRCRESAHA.108.183087. Review.

18.

[Hypertension-induced fibrosis: a balance story].

Azibani F, Fazal L, Chatziantoniou C, Samuel JL, Delcayre C.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):150-5. doi: 10.1016/j.ancard.2012.05.004. Epub 2012 May 25. French.

PMID:
22681982
19.

The function of miRNA in cardiac hypertrophy.

Wang J, Yang X.

Cell Mol Life Sci. 2012 Nov;69(21):3561-70. doi: 10.1007/s00018-012-1126-y. Epub 2012 Aug 25. Review.

20.

Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.

Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S.

Circ Res. 2008 Oct 10;103(8):891-9. doi: 10.1161/CIRCRESAHA.108.175141. Epub 2008 Sep 5.

Supplemental Content

Support Center